BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization Medical Device Investing
BioSig Technologies Advances Towards Commercialization into the Global Electrophysiology Market Estimated to Reach $8.2 Billion by 2022 Medical Device Investing
LED Medical Diagnostics Announces Proposed Issuance of Senior Secured Debentures Medical Device Investing
Imagin Medical Closing Second and Final Tranche of $1,000,000 Private Placement Medical Device Investing
BioSig Technologies to Present at the Dawson James Small Cap Growth Conference Medical Device Investing
BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer Medical Device Investing